InsidersTradesSigma
Follow the 엘앤케이바이오 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 엘앤케이바이오 has recorded 3 public disclosures. Market capitalisation: €75.8bn. The latest transaction was filed on 6 July 2026 (Purchase). Among the most active insiders: 강국진. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
엘앤케이바이오是一家在XKRX市场上市的医疗保健和制药领域的公司。它专注于生物制药解决方案的开发。